| Phase 2/31 trial |
|
Phase 2/3
|
NCT01174992 |
Jul 2010 → Sep 2011 |
craniofacial and skeletal defects |
Ethicon, Inc. |
Completed
|
No outcome recorded
|
| Phase 33 trials · 1 met primary |
|
Phase 3
|
NCT02309645 |
Oct 2014 → Aug 2021 |
cerebrospinal fluid leak |
Ethicon, Inc. |
Terminated
|
No outcome recorded
Stop: Enrollment |
|
Phase 3
|
NCT02227706 |
Aug 2014 → Apr 2019 |
hemorrhagic disease |
Ethicon, Inc. |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT00154141 |
Jun 2005 → Mar 2006 |
peripheral vascular disease |
Ethicon, Inc. |
Completed
|
Met primary
|
| Phase not applicable2 trials · 1 missed |
| — |
NCT01816282 |
Mar 2011 → Apr 2012 |
osteoarthritis, knee |
University of Milan |
Completed
|
Missed primary
|
| — |
NCT01226914 |
Jun 2010 → Jul 2014 |
goiter, thyroid tumor |
Medical University of South Carolina |
Completed
|
No outcome recorded
|
| Comparator or background therapy3 trials |
|
Phase 3
|
NCT03461406 Comparator |
Jan 2019 → Apr 2022 |
— |
Grifols, S.A. |
Completed
|
Met primary
|
|
Phase 3
|
NCT02553122 Comparator |
Oct 2015 → Oct 2016 |
osteoarthritis, knee |
Montefiore Medical Center |
Withdrawn
|
No outcome recorded
|
|
Phase 4
|
NCT01235715 Comparator |
Sep 2010 → Mar 2012 |
osteoarthritis |
Hospital for Special Surgery, New York |
Completed
|
No outcome recorded
|